Viewing Study NCT00003002


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2025-12-26 @ 2:46 AM
Study NCT ID: NCT00003002
Status: COMPLETED
Last Update Posted: 2019-02-27
First Post: 1999-11-01
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: HER-2/Neu Vaccine Plus GM-CSF in Treating Patients With Stage III or Stage IV Breast, Ovarian, or Non-small Cell Lung Cancer
Sponsor: University of Washington
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module